Emergency Management of Stroke Bridging Trial "EMS"

Completed

Phase N/A Results

Summary of Purpose

To test the feasibility, efficacy and safety of combined intravenous (IV) and intraarterial (IA) recombinant tissue plasminogen activator (rt-PA) within 3 hours of stroke symptom onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Genentech, Inc.

Trial Design

Double-blind, randomized, placebo-controlled, multi-center trial involving 36 patients.

Contacts

  • Thomas Brott, M.D., Mayo clinic Jacksonville, Department of Neurology, 4500 San Pablo Rd., Jacksonville, FL, 32224

    brott.thomas@mayo.edu